Abstract: Cardiovascular diseases represent a relevant problem worldwide. Data from World Health Organization(W.H.O.) demonstrate that they are one of the principle causes of death: the 30% of all the losses of human life in theworld are due to heart diseases. Such a data bury a substantial economic cost considering both the direct component, firstof all the national health expense, and the indirect part, such as absenteeism rate, productivity loss, quality of life and,more generally, social costs. The future scenario pictured by the W.H.O. reveals a negative trend due to an increasing inthe rate of morbidity and mortality especially in the Emerging Countries. One of the solution to stem the costs – economicand not – connected to cardiovascular diseases is to empower the prevention activities overall the actions of primary prevention.This require a change in the traditional patient-physician relationship management model to get to an organizationalmodel centred on patient and based on a proactive approach. In this perspective in the paper will be analysed theprincipal changes happened in the Italian national healthcare system and in particular the strategic plans and actions intheme of cardiovascular prevention.

Cardiovascular disease: an economical perspective / Lazzini, Arianna; S., Lazzini. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1381-6128. - STAMPA. - 15:10(2009), pp. 1142-1156. [10.2174/138161209787846883]

Cardiovascular disease: an economical perspective

LAZZINI, Arianna;
2009

Abstract

Abstract: Cardiovascular diseases represent a relevant problem worldwide. Data from World Health Organization(W.H.O.) demonstrate that they are one of the principle causes of death: the 30% of all the losses of human life in theworld are due to heart diseases. Such a data bury a substantial economic cost considering both the direct component, firstof all the national health expense, and the indirect part, such as absenteeism rate, productivity loss, quality of life and,more generally, social costs. The future scenario pictured by the W.H.O. reveals a negative trend due to an increasing inthe rate of morbidity and mortality especially in the Emerging Countries. One of the solution to stem the costs – economicand not – connected to cardiovascular diseases is to empower the prevention activities overall the actions of primary prevention.This require a change in the traditional patient-physician relationship management model to get to an organizationalmodel centred on patient and based on a proactive approach. In this perspective in the paper will be analysed theprincipal changes happened in the Italian national healthcare system and in particular the strategic plans and actions intheme of cardiovascular prevention.
2009
15
10
1142
1156
Cardiovascular disease: an economical perspective / Lazzini, Arianna; S., Lazzini. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1381-6128. - STAMPA. - 15:10(2009), pp. 1142-1156. [10.2174/138161209787846883]
Lazzini, Arianna; S., Lazzini
File in questo prodotto:
File Dimensione Formato  
A.Lazzini_CPD_2009.pdf

Solo gestori archivio

Tipologia: Versione pubblicata dall'editore
Dimensione 906.02 kB
Formato Adobe PDF
906.02 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/609697
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 9
social impact